Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial-Reference-Cited by-同舟云学术

Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial

Published:2010-08-24 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Dollinger Matthias M, ,Lautenschlaeger Christine,Lesske Joachim,Tannapfel Andrea,Wagner Anna-Dorothea,Schoppmeyer Konrad,Nehls Oliver,Welker Martin-Walter,Wiest Reiner,Fleig Wolfgang E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-457.pdf

Reference26 articles.

1. Bosch FX, Ribes J, Díaz M, et al: Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004, 127: S5-S16. 10.1053/j.gastro.2004.09.011.

2. Burroughs A, Hochhauser D, Meyer T: Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol. 2004, 5: 409-418. 10.1016/S1470-2045(04)01508-6.

3. Beaugrand M, N'kontchou G, Seror O, et al: Local/regional and systemic treatments of hepatocellular carcinoma. Semin Liver Dis. 2005, 25: 201-211. 10.1055/s-2005-871199.

4. Bruix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002, 35: 519-524. 10.1053/jhep.2002.32089.

5. Fleig WE, Lesske J: Hepatocellular carcinoma: Primary and secondary prophylaxis as well as medical therapy. Chir Gastroenterol. 2003, 19: 247-252. 10.1159/000074010.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020);Gastroenterology;2021-09

3. Milestones in the treatment of hepatocellular carcinoma: A systematic review.;Critical Reviews in Oncology/Hematology;2021-01

4. Value of quality of life analysis in liver cancer: A clinician’s perspective;World Journal of Hepatology;2017

5. Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence;Oncology Letters;2016-12-20